Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04411173 · ClinicalTrials.gov registry record · NA

Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations

A NA study of Hypertrophy, sponsored by Lindenwood University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04411173 is a NA study of Hypertrophy that has completed, run by Lindenwood University. The registered enrollment target is 24 participants, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04411173, a NA study of Hypertrophy, has completed, sponsored by Lindenwood University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the ability of isocaloric and isonitrogenous (2 x 15-gram) doses of rice protein or whey protein to stimulate resistance training adaptations in young, healthy, resistance-trained men.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey Protein

Study Locations (1)

Missouri

  • Lindenwood University - Saint Charles

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-09-12
Est. Completion 2020-02-12
Phase NA

Sponsor

Lindenwood University

29 total trials

What the Registry Record Tells You About NCT04411173

The ClinicalTrials.gov registry entry for NCT04411173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 32-participant average among 4 other Hypertrophy trials with a reported enrollment target (25% lower). The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertrophy appearing as the primary indexed condition, and to 1 intervention - of which Whey Protein is the first listed.

NCT04411173 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04411173 about?

NCT04411173 is a clinical study titled "Effect of Daily Doses of Rice or Whey Protein on Resistance Training Adaptations". The purpose of this study is to compare the ability of isocaloric and isonitrogenous (2 x 15-gram) doses of rice protein or whey protein to stimulate resistance training adaptations in young, healthy, resistance-trained men.

What is the current status of trial NCT04411173?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-09-12. Estimated completion is 2020-02-12.

What conditions does trial NCT04411173 study?

This clinical trial studies the following conditions: Hypertrophy.

What interventions are being tested in trial NCT04411173?

The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04411173?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04411173 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.